Document Detail


BORIS, Brother of the Regulator of Imprinted Sites, Is Aberrantly Expressed in Hepatocellular Carcinoma.
MedLine Citation:
PMID:  23237599     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Background: The brother of the regulator of imprinted sites (BORIS) is a novel member of the cancer testis antigen gene family, which are normally expressed only in spermatocytes, but abnormally activated in different malignancies. Aim: The aim of this study was to explore the expression of BORIS in hepatocellular carcinoma (HCC) and its correlation with the clinicopathologic features and prognosis of HCC. Methods: We investigated BORIS expression in HCC cell lines and 105 primary HCC clinical surgical specimens using real-time polymerase chain reaction and Western blot analysis. We further examined the correlation of BORIS with a liver stem cell marker (CD90) in HCC tissues by histochemical double staining. The correlation of BORIS with clinicopathologic features and prognosis of HCC was analyzed using patient data. Results: The expression of BORIS was found in SMMC-7721, BEL-7402, and Huh-7, but not in hep-G2 cells. The expression rate of BORIS was significantly higher in the HCC tissues than in the adjacent noncancerous tissues (p=0.000). BORIS expression was correlated with the tumor size (p=0.000), CD90 expression (p=0.000), and satellite nodule (p=0.000). Kaplan-Meier survival curves showed that patients with positive expression of BORIS had lower overall survival rate (p=0.003). Conclusions: Our data indicate that BORIS may be an auxiliary diagnosis index and a novel favorable prognostic indicator of HCC.
Authors:
Kefei Chen; Wenqing Huang; Bin Huang; Yonggang Wei; Bo Li; Yan Ge; Yang Qin
Related Documents :
11703459 - Biological activity of re-1 silencing transcription factor (rest) towards distinct tran...
22960219 - Chicken fto gene: tissue-specific expression, brain distribution, breed difference and ...
23055189 - Ing4 is negatively correlated with microvessel density in colon cancer.
23562819 - Genetic regulation of human adipose microrna expression and its consequences for metabo...
23102249 - Expression and clinical significance of cd82/kai1 and e-cadherin in non-small cell lung...
8074479 - Expression of metallopanstimulin in condylomata acuminata of the female anogenital regi...
8684009 - Chronic myeloid leukemia of thrombocythemic onset: a cml subtype with distinct hematolo...
9726119 - Ultrastructural characterization of atrial natriuretic peptide receptors (anp-r) mrna e...
11073079 - Cloning of full length cdna, high-level expression and biological characterization of f...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-13
Journal Detail:
Title:  Genetic testing and molecular biomarkers     Volume:  -     ISSN:  1945-0257     ISO Abbreviation:  Genet Test Mol Biomarkers     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101494210     Medline TA:  Genet Test Mol Biomarkers     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1 Division of Liver Transplantation, Department of Surgery, West China Hospital , Chengdu, China .
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ovarian aging: melatonin regulation of the cytometric and endocrine evolutive pattern.
Next Document:  Nonmuscle myosin II folds into a 10S form via two portions of tail for dynamic subcellular localizat...